These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 12176958)

  • 1. Anticoagulant responses to thrombin are enhanced during regression of atherosclerosis in monkeys.
    Lentz SR; Miller FJ; Piegors DJ; Erger RA; Fernández JA; Griffin JH; Heistad DD
    Circulation; 2002 Aug; 106(7):842-6. PubMed ID: 12176958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired anticoagulant response to infusion of thrombin in atherosclerotic monkeys associated with acquired defects in the protein C system.
    Lentz SR; Fernández JA; Griffin JH; Piegors DJ; Erger RA; Malinow MR; Heistad DD
    Arterioscler Thromb Vasc Biol; 1999 Jul; 19(7):1744-50. PubMed ID: 10397693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supplementation of atherogenic diet with B vitamins does not prevent atherosclerosis or vascular dysfunction in monkeys.
    Lentz SR; Piegors DJ; Malinow MR; Heistad DD
    Circulation; 2001 Feb; 103(7):1006-11. PubMed ID: 11181477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consequences of hyperhomocyst(e)inemia on vascular function in atherosclerotic monkeys.
    Lentz SR; Malinow MR; Piegors DJ; Bhopatkar-Teredesai M; Faraci FM; Heistad DD
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2930-4. PubMed ID: 9409278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of hyperhomocysteinemia on protein C activation and activity.
    Lentz SR; Piegors DJ; Fernández JA; Erger RA; Arning E; Malinow MR; Griffin JH; Bottiglieri T; Haynes WG; Heistad DD
    Blood; 2002 Sep; 100(6):2108-12. PubMed ID: 12200374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet factor 4 enhances generation of activated protein C in vitro and in vivo.
    Slungaard A; Fernandez JA; Griffin JH; Key NS; Long JR; Piegors DJ; Lentz SR
    Blood; 2003 Jul; 102(1):146-51. PubMed ID: 12609838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of atherosclerosis and regression on vascular responses to products of activated platelets in primates.
    Lopez JA; Armstrong ML; Brotherton AF; Piegors DJ; Heistad DD
    Am J Physiol; 1991 Apr; 260(4 Pt 2):H1051-6. PubMed ID: 2012210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular responses to activated leukocytes after regression of atherosclerosis.
    Padgett RC; Heistad DD; Mügge A; Armstrong ML; Piegors DJ; Lopez JA
    Circ Res; 1992 Feb; 70(2):423-9. PubMed ID: 1735139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of short-term regression of atherosclerosis on reactivity of carotid and retinal arteries.
    Sobey CG; Faraci FM; Piegors DJ; Heistad DD
    Stroke; 1996 May; 27(5):927-33. PubMed ID: 8623115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia.
    Lentz SR; Sobey CG; Piegors DJ; Bhopatkar MY; Faraci FM; Malinow MR; Heistad DD
    J Clin Invest; 1996 Jul; 98(1):24-9. PubMed ID: 8690798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional improvement precedes structural regression of atherosclerosis.
    Benzuly KH; Padgett RC; Kaul S; Piegors DJ; Armstrong ML; Heistad DD
    Circulation; 1994 Apr; 89(4):1810-8. PubMed ID: 8149547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limited generation of activated protein C during infusion of the protein C activator thrombin analog W215A/E217A in primates.
    Gruber A; Fernández JA; Bush L; Marzec U; Griffin JH; Hanson SR; DI Cera E
    J Thromb Haemost; 2006 Feb; 4(2):392-7. PubMed ID: 16420571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of atherosclerosis regression in Macaca mulatta: III. Chemical changes in arteries from animals with atherosclerosis induced for 19 months and regressed for 48 months at plasma cholesterol concentrations of 300 or 200 mg/dl.
    Wagner WD; St Clair RW; Clarkson TB; Connor JR
    Am J Pathol; 1980 Sep; 100(3):633-50. PubMed ID: 7416234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antithrombotic effects of recombinant human soluble thrombomodulin (rhsTM) on tissue factor-induced disseminated intravascular coagulation in crab-eating monkeys (Macaca fascicularis).
    Mohri M; Gonda Y; Oka M; Aoki Y; Gomi K; Kiyota T; Sugihara T; Yamamoto S; Ishida T; Maruyama I
    Blood Coagul Fibrinolysis; 1997 Jul; 8(5):274-83. PubMed ID: 9282791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary polyunsaturated fat modifies low-density lipoproteins and reduces atherosclerosis of nonhuman primates with high and low diet responsiveness.
    Rudel LL; Johnson FL; Sawyer JK; Wilson MS; Parks JS
    Am J Clin Nutr; 1995 Aug; 62(2):463S-470S. PubMed ID: 7625361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of protein C activation by histones, platelet factor 4, and heparinoids: new insights into activated protein C formation.
    Kowalska MA; Zhao G; Zhai L; David G; Marcus S; Krishnaswamy S; Poncz M
    Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):120-6. PubMed ID: 24177324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced protein C activation and inhibition of fibrinogen cleavage by a thrombin modulator.
    Berg DT; Wiley MR; Grinnell BW
    Science; 1996 Sep; 273(5280):1389-91. PubMed ID: 8703074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of thrombin generation by protein S at low procoagulant stimuli: implications for maintenance of the hemostatic balance.
    Seré KM; Rosing J; Hackeng TM
    Blood; 2004 Dec; 104(12):3624-30. PubMed ID: 15292065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aneurysm formation in experimental atherosclerosis: relationship to plaque evolution.
    Zarins CK; Glagov S; Vesselinovitch D; Wissler RW
    J Vasc Surg; 1990 Sep; 12(3):246-56. PubMed ID: 2398583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro profile and ex-vivo anticoagulant activity of the direct thrombin inhibitor dabigatran and its orally active prodrug, dabigatran etexilate.
    Wienen W; Stassen JM; Priepke H; Ries UJ; Hauel N
    Thromb Haemost; 2007 Jul; 98(1):155-62. PubMed ID: 17598008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.